Answers are grounded in this paper and cite their sources.
Chronic wounds present complex healing challenges due to bacterial infection, persistent inflammation, and dysregulated extracellular matrix remodeling. Although isoliquiritigenin (ISL) exhibits potent anti-inflammatory, antibacterial, and antifibrotic properties, its low aqueous solubility hinders direct hydrogel incorporation. Here, alginate (Alg)- and chitosan/alginate (Cht/Alg)-based hydrogels were developed for localized ISL delivery, using Tween 20 (Tw20) or decyl glucoside (DecGlu) as non-ionic surfactants to enhance compound release. Polymer composition and surfactant addition significantly influenced hydrogel morphology, swelling, surface chemistry, micromechanical properties, and porosity. Surfactant-enriched Alg formulations increased ISL release by 52–76% within 24 h. In vitro assays demonstrated high cytocompatibility for Cht/Alg systems (>80% viability in MTT and >90% in crystal violet/LDH assays at 144 h), whereas the Alg/Tw20 formulation exhibited cytotoxicity. ISL-containing extracts significantly attenuated TGF-β 1 induced fibroblast-to-myofibroblast transition, reducing α-SMA-positive cells by 50% for Alg and 29% for Cht/Alg, with DecGlu further reducing them to 15.0% and 20.0%, respectively. ISL also reduced total collagen I and fibronectin protein levels. Furthermore, Cht/Alg hydrogels exhibited marked antibacterial activity, achieving 4- and 5-log reductions in Staphylococcus aureus and Pseudomonas aeruginosa , respectively. Overall, ISL-enriched Cht/Alg-DecGlu hydrogels represent a promising multifunctional wound-contact platform combining localized bioactive delivery, excellent cytocompatibility, antibacterial efficacy, and potent modulation of profibrotic responses.
No takes yet. Share an insight, caveat, or question.
Tymetska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: